Goldman Sachs’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q2 | – | Sell |
-1,733,556
| Closed | -$300M | – | 4902 |
|
|
2015
Q1 | $300M | Buy |
1,733,556
+611,026
| +54% | +$106M | 0.1% | 178 |
|
|
2014
Q4 | $129M | Buy |
1,122,530
+236,813
| +27% | +$27.2M | 0.04% | 419 |
|
|
2014
Q3 | $138M | Buy |
885,717
+396,345
| +81% | +$61.9M | 0.04% | 378 |
|
|
2014
Q2 | $60.4M | Buy |
489,372
+199,997
| +69% | +$24.7M | 0.02% | 724 |
|
|
2014
Q1 | $30M | Buy |
289,375
+176,801
| +157% | +$18.3M | 0.01% | 1029 |
|
|
2013
Q4 | $10.1M | Sell |
112,574
-30,839
| -22% | -$2.77M | ﹤0.01% | 1569 |
|
|
2013
Q3 | $9.59M | Buy |
143,413
+33,075
| +30% | +$2.21M | ﹤0.01% | 1519 |
|
|
2013
Q2 | $7.3M | Buy |
+110,338
| New | +$7.3M | ﹤0.01% | 1547 |
|